These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Delayed onset of paresis in rats with experimental intramedullary spinal cord gliosarcoma following intratumoral administration of the paclitaxel delivery system OncoGel. Tyler BM; Hdeib A; Caplan J; Legnani FG; Fowers KD; Brem H; Jallo G; Pradilla G J Neurosurg Spine; 2012 Jan; 16(1):93-101. PubMed ID: 22208429 [TBL] [Abstract][Full Text] [Related]
5. A thermal gel depot for local delivery of paclitaxel to treat experimental brain tumors in rats. Tyler B; Fowers KD; Li KW; Recinos VR; Caplan JM; Hdeib A; Grossman R; Basaldella L; Bekelis K; Pradilla G; Legnani F; Brem H J Neurosurg; 2010 Aug; 113(2):210-7. PubMed ID: 20001591 [TBL] [Abstract][Full Text] [Related]
6. Intraosseous delivery of paclitaxel-loaded hydroxyapatitealginate composite beads delaying paralysis caused by metastatic spine cancer in rats. Abe T; Sakane M; Ikoma T; Kobayashi M; Nakamura S; Ochiai N J Neurosurg Spine; 2008 Nov; 9(5):502-10. PubMed ID: 18976182 [TBL] [Abstract][Full Text] [Related]
7. Delayed onset of paralysis and slowed tumor growth following in situ placement of recombinant human bone morphogenetic protein 2 within spine tumors in a rat model of metastatic breast cancer. Molina CA; Sarabia-Estrada R; Gokaslan ZL; Witham TF; Bydon A; Wolinsky JP; Sciubba DM J Neurosurg Spine; 2012 Apr; 16(4):365-72. PubMed ID: 22264176 [TBL] [Abstract][Full Text] [Related]
8. EUS-guided injection of paclitaxel (OncoGel) provides therapeutic drug concentrations in the porcine pancreas (with video). Matthes K; Mino-Kenudson M; Sahani DV; Holalkere N; Fowers KD; Rathi R; Brugge WR Gastrointest Endosc; 2007 Mar; 65(3):448-53. PubMed ID: 17173909 [TBL] [Abstract][Full Text] [Related]
9. Phase 1 study of escalating-dose OncoGel (ReGel/paclitaxel) depot injection, a controlled-release formulation of paclitaxel, for local management of superficial solid tumor lesions. Vukelja SJ; Anthony SP; Arseneau JC; Berman BS; Cunningham CC; Nemunaitis JJ; Samlowski WE; Fowers KD Anticancer Drugs; 2007 Mar; 18(3):283-9. PubMed ID: 17264760 [TBL] [Abstract][Full Text] [Related]
10. Surgical resection plus adjuvant radiotherapy is superior to surgery or radiotherapy alone in the prevention of neurological decline in a rat metastatic spinal tumor model. Gok B; McGirt M; Sciubba DM; Ayhan S; Bydon A; Witham TF; Wolinsky JP; Gokaslan ZL Neurosurgery; 2008 Aug; 63(2):346-51; discussion 351. PubMed ID: 18797365 [TBL] [Abstract][Full Text] [Related]
11. Combination of paclitaxel thermal gel depot with temozolomide and radiotherapy significantly prolongs survival in an experimental rodent glioma model. Vellimana AK; Recinos VR; Hwang L; Fowers KD; Li KW; Zhang Y; Okonma S; Eberhart CG; Brem H; Tyler BM J Neurooncol; 2013 Feb; 111(3):229-36. PubMed ID: 23224713 [TBL] [Abstract][Full Text] [Related]
12. A novel rat model for the study of intraosseous metastatic spine cancer. Mantha A; Legnani FG; Bagley CA; Gallia GL; Garonzik I; Pradilla G; Amundson E; Tyler BM; Brem H; Gokaslan ZL J Neurosurg Spine; 2005 Mar; 2(3):303-7. PubMed ID: 15796355 [TBL] [Abstract][Full Text] [Related]
13. OncoGel (ReGel/paclitaxel)--clinical applications for a novel paclitaxel delivery system. Elstad NL; Fowers KD Adv Drug Deliv Rev; 2009 Aug; 61(10):785-94. PubMed ID: 19422870 [TBL] [Abstract][Full Text] [Related]
14. Effect of hyperglycemia on progressive paraparesis in a rat etastatic spinal tumor model. McGirt MJ; Gok B; Shepherd S; Noggle J; Garcés Ambrossi GL; Bydon A; Gokaslan ZL J Neurosurg Spine; 2009 Jan; 10(1):9-15. PubMed ID: 19119926 [TBL] [Abstract][Full Text] [Related]
15. Photodynamic therapy with indocyanine green injection and near-infrared light irradiation has phototoxic effects and delays paralysis in spinal metastasis. Funayama T; Sakane M; Abe T; Ochiai N Photomed Laser Surg; 2012 Jan; 30(1):47-53. PubMed ID: 22043821 [TBL] [Abstract][Full Text] [Related]
16. A rat model of metastatic spinal cord compression using human prostate adenocarcinoma: histopathological and functional analysis. Sarabia-Estrada R; Zadnik PL; Molina CA; Jimenez-Estrada I; Groves ML; Gokaslan ZL; Bydon A; Witham TF; Wolinsky JP; Sciubba DM Spine J; 2013 Nov; 13(11):1597-606. PubMed ID: 23810458 [TBL] [Abstract][Full Text] [Related]
17. A novel model of intramedullary spinal cord tumors in rats: functional progression and histopathological characterization. Caplan J; Pradilla G; Hdeib A; Tyler BM; Legnani FG; Bagley CA; Brem H; Jallo G Neurosurgery; 2006 Jul; 59(1):193-200; discussion 193-200. PubMed ID: 16823316 [TBL] [Abstract][Full Text] [Related]
18. Phase 2: a dose-escalation study of OncoGel (ReGel/paclitaxel), a controlled-release formulation of paclitaxel, as adjunctive local therapy to external-beam radiation in patients with inoperable esophageal cancer. DuVall GA; Tarabar D; Seidel RH; Elstad NL; Fowers KD Anticancer Drugs; 2009 Feb; 20(2):89-95. PubMed ID: 19209024 [TBL] [Abstract][Full Text] [Related]
19. Characterization of intratumor magnetic nanoparticle distribution and heating in a rat model of metastatic spine disease. Zadnik PL; Molina CA; Sarabia-Estrada R; Groves ML; Wabler M; Mihalic J; McCarthy EF; Gokaslan ZL; Ivkov R; Sciubba D J Neurosurg Spine; 2014 Jun; 20(6):740-50. PubMed ID: 24702509 [TBL] [Abstract][Full Text] [Related]